Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer

Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer

Neoantigens are optimal tumor-specific targets for T-cell based immunotherapy, especially for patients with “undruggable” mutated driver genes. T-cell immunotherapy can be a “universal” treatment for HLA genotype patients sharing same oncogenic mutations. To identify potential neoantigens for therap...

Full description

Bibliographic Details
Main Authors: Jie Zhou, Wenyi Zhao, Jingcheng Wu, Jun Lu, Yongfeng Ding, Shanshan Wu, Haiyong Wang, Ding Ding, Fan Mo, Zhan Zhou, Lisong Teng, Shuqing Chen
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2019/8103142

Internet

http://dx.doi.org/10.1155/2019/8103142

Similar Items